Top Markets
Coin of the day
Accelerate Diagnostics, Inc. Accelerate Diagnostics, Inc.

Accelerate Diagnostics, Inc.

AXDX
株式のランク #40437
Accelerate Diagnostics, Inc. is an in vitro diagnostics company specializing in... Accelerate Diagnostics, Inc. is an in vitro diagnostics company specializing in solutions for the rapid diagnosis of critical infections, with operations spanning the United States, Europe, and the Middle East. The company's primary offering is the Accelerate Pheno system, an advanced in vitro diagnostic platform. Paired with its dedicated test kit, the Accelerate PhenoTest, this system facilitates quick identification and antimicrobial susceptibility testing (AST) for pathogens responsible for severe or healthcare-associated infections, encompassing both Gram-positive and Gram-negative organisms. The PhenoTest is specifically designed to yield crucial ID and AST results for patients suspected of bacteremia or fungemia – life-threatening conditions marked by high morbidity and mortality risks. Established in 1982, the company initially operated as Accelr8 Technology Corporation before adopting its current name, Accelerate Diagnostics, Inc., in December 2012. Its corporate headquarters are located in Tucson, Arizona.
株価
$0.01005
最終同期: 2025-06-09
時価総額
$146.42K
変化(1日)
-28.21%
変化(1年)
0.00%
US
取引 Accelerate Diagnostics, Inc. (AXDX)

カテゴリー

Accelerate Diagnostics, Inc.(AXDX)の株価履歴
終値の最高値: $0.01 (2025-06-01)

終値の最安値: $3.75 (1994-04-01)
Accelerate Diagnostics, Inc. の株価履歴(1994 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2025 -99.20%
2024 -70.17%
2023 -34.72%
2022 -86.17%
2021 -34.48%
2020 -54.26%
2019 29.97%
2018 -54.93%
2017 23.47%
2016 8.82%
2015 12.63%
2014 35.33%
2013 285.24%
2012 165.76%
2011 30.60%
2010 18.58%
2009 -64.05%
2008 -42.44%
2007 113.96%
2006 -37.00%
2005 39.31%
2004 -8.99%
2003 65.77%
2002 -34.53%
2001 619.37%
2000 -76.37%
1999 -61.68%
1998 -84.87%
1997 101.66%
1996 2,145.85%
1995 102.39%
1994 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$111.44 -13.88%
US
$341.38 -9.91%
US
$90.60 -2.49%
IE
$51.77 -49.49%
US
$92.54 19.12%
US